Trade Sino Biopharmaceutical Limited - 1177 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021452% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000466% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 100 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.86 |
| Open | 4.04 |
| 1-Year Change | 53.03% |
| Day's Range | 3.9 - 4.04 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 3.92 | -0.02 | -0.51% | 3.94 | 4.06 | 3.90 |
| Apr 24, 2025 | 3.86 | 0.04 | 1.05% | 3.82 | 3.90 | 3.80 |
| Apr 23, 2025 | 3.82 | -0.06 | -1.55% | 3.88 | 3.90 | 3.80 |
| Apr 22, 2025 | 3.82 | 0.18 | 4.95% | 3.64 | 3.84 | 3.64 |
| Apr 17, 2025 | 3.66 | 0.08 | 2.23% | 3.58 | 3.66 | 3.58 |
| Apr 16, 2025 | 3.58 | -0.10 | -2.72% | 3.68 | 3.68 | 3.52 |
| Apr 15, 2025 | 3.70 | -0.04 | -1.07% | 3.74 | 3.76 | 3.66 |
| Apr 14, 2025 | 3.72 | 0.12 | 3.33% | 3.60 | 3.74 | 3.58 |
| Apr 11, 2025 | 3.56 | 0.16 | 4.71% | 3.40 | 3.58 | 3.40 |
| Apr 10, 2025 | 3.40 | 0.02 | 0.59% | 3.38 | 3.52 | 3.38 |
| Apr 9, 2025 | 3.40 | 0.14 | 4.29% | 3.26 | 3.42 | 3.16 |
| Apr 8, 2025 | 3.38 | 0.04 | 1.20% | 3.34 | 3.42 | 3.28 |
| Apr 7, 2025 | 3.30 | -0.20 | -5.71% | 3.50 | 3.54 | 3.26 |
| Apr 3, 2025 | 3.90 | 0.02 | 0.52% | 3.88 | 3.96 | 3.80 |
| Apr 2, 2025 | 3.94 | 0.10 | 2.60% | 3.84 | 3.98 | 3.80 |
| Apr 1, 2025 | 3.84 | 0.12 | 3.23% | 3.72 | 3.90 | 3.70 |
| Mar 31, 2025 | 3.74 | 0.08 | 2.19% | 3.66 | 3.78 | 3.60 |
| Mar 28, 2025 | 3.70 | 0.02 | 0.54% | 3.68 | 3.78 | 3.62 |
| Mar 27, 2025 | 3.62 | 0.04 | 1.12% | 3.58 | 3.70 | 3.54 |
| Mar 26, 2025 | 3.58 | 0.04 | 1.13% | 3.54 | 3.62 | 3.52 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Sino Biopharmeceutical Company profile
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.| Industry: | Pharmaceuticals (NEC) |
湾仔港湾道1号会展广场辨公大楼41楼09室
HK
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com